Zacks Investment Research on MSN
Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know
Moderna (MRNA) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) declares $0.0221/share weekly dividend. Payable Oct. 17; for shareholders of record Oct. 16; ex-div Oct. 16. See MRNY Dividend Scorecard, Yield ...
The federal government is cutting $500 million in research money for development of mRNA vaccines, which were widely used against the COVID-19 virus. Health Secretary Robert F. Kennedy Jr. said in a ...
Moderna is expected to announce its third-quarter results next month, and analysts expect a significant loss per share.
In earlier laboratory experiments, researchers had observed that mRNA vaccines improve the effectiveness of cancer drugs such ...
WASHINGTON (AP) — So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel Prize-winning technology to try to develop vaccines and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback